Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -73.27% is in line with its 5-year average of -70.62%, around the middle of its 5-year range (-125.39%–-27.26%).
As of the fiscal period ended Tuesday, June 30, 2026. 24.76% below its 12-month average of -58.73%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -73.27%.
RETURN ON INVESTED CAPITAL (ROIC)
-73.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-58.73%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-56.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-70.62%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-24.76%
CURRENT VS 3Y AVG
-29.19%
CURRENT VS 5Y AVG
-3.76%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 826 covered companies
CURRENT VS SECTOR MEDIAN
-105.56%
vs the sector median at left
Helus Pharma Inc.
Market Cap
$668.50M
Return on Invested Capital (ROIC)
-73.27%
TTM Avg
-58.73%
3Y Avg
-56.72%
5Y Avg
-70.62%
Market Cap
$668.98M
Return on Invested Capital (ROIC)
1.97%
TTM Avg
18.16%
3Y Avg
11.04%
5Y Avg
1.26%
Market Cap
$666.78M
Return on Invested Capital (ROIC)
-44.30%
TTM Avg
-32.94%
3Y Avg
-36.44%
5Y Avg
-31.30%
Market Cap
$664.38M
Return on Invested Capital (ROIC)
-101.43%
TTM Avg
-70.16%
3Y Avg
-61.78%
5Y Avg
-52.46%
Market Cap
$664.16M
Return on Invested Capital (ROIC)
-47.96%
TTM Avg
-47.20%
3Y Avg
-41.20%
5Y Avg
-37.18%
Market Cap
$657.51M
Return on Invested Capital (ROIC)
-31.32%
TTM Avg
-38.51%
3Y Avg
-38.51%
5Y Avg
-38.51%
Market Cap
$679.70M
Return on Invested Capital (ROIC)
-118.97%
TTM Avg
-130.14%
3Y Avg
-108.49%
5Y Avg
-89.69%
Market Cap
$682.26M
Return on Invested Capital (ROIC)
-54.12%
TTM Avg
-85.96%
3Y Avg
-71.51%
5Y Avg
-63.27%
Market Cap
$697.52M
Return on Invested Capital (ROIC)
-50.92%
TTM Avg
-35.84%
3Y Avg
-41.63%
5Y Avg
-32.97%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Helus Pharma Inc. (HELP) | $668.50M | -73.27% | -58.73% | -56.72% | -70.62% |
| MiMedx Group, Inc. (MDXG)vs › | $668.98M | 1.97% | 18.16% | 11.04% | 1.26% |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $666.78M | -44.30% | -32.94% | -36.44% | -31.30% |
| Annexon, Inc. (ANNX)vs › | $664.38M | -101.43% | -70.16% | -61.78% | -52.46% |
| ArriVent BioPharma, Inc. (AVBP)vs › | $664.16M | -47.96% | -47.20% | -41.20% | -37.18% |
| Starling Oncology, Inc. (STLN)vs › | $657.51M | -31.32% | -38.51% | -38.51% | -38.51% |
| Verastem, Inc. (VSTM)vs › | $679.70M | -118.97% | -130.14% | -108.49% | -89.69% |
| Solid Biosciences Inc. (SLDB)vs › | $682.26M | -54.12% | -85.96% | -71.51% | -63.27% |
| Olema Pharmaceuticals, Inc. (OLMA)vs › | $697.52M | -50.92% | -35.84% | -41.63% | -32.97% |
| OmniAb, Inc. (OABI)vs › | $639.31M | -17.48% | -24.56% | -18.89% | -16.21% |
ROIC
-73.3%
ROE
-75.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -73.27% |
| 2026-03-31 | -47.63% |
| 2025-12-31 | -47.21% |
| 2025-09-30 | -47.15% |
| 2025-06-30 | -78.40% |
| 2025-03-31 | -60.18% |
| 2024-12-31 | -56.72% |
| 2024-09-30 | -49.19% |
| 2024-06-30 | -29.38% |
| 2024-03-31 | -27.26% |
| 2023-12-31 | -55.03% |
| 2023-09-30 | -109.16% |
| 2023-06-30 | -125.39% |
| 2023-03-31 | -107.56% |
| 2022-12-31 | -99.36% |
| 2022-09-30 | -97.76% |
| 2022-06-30 | -94.35% |
| 2022-03-31 | -83.44% |
| 2021-12-31 | -68.11% |
| 2021-09-30 | -55.83% |
| 2019-01-31 | -25.85% |
| 2018-07-31 | -51.46% |
